$ADMS Adamas Pharmaceuticals Inc Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adamas Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Adamas Pharmaceuticals Inc. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Adamas Pharmaceuticals Inc Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| aeris Capital Equity Investments, L.P. | 10% Owner | 1,662,128 | 26,859,988 | Mar 17 2015 | |||
| aeris Capital Equity Investments, L.P. | 10% Owner | 2,012,128 | 32,515,988 | Dec 04 2014 | |||
| BIGHAM MICHAEL | Director | 10,000 | 161,600 | Jun 04 2021 | |||
| BOOTH RICHARD H | Director | 45,778 | 739,772 | Jun 07 2016 | |||
| BOOTH RICHARD H | Director | 49,778 | 804,412 | Feb 18 2015 | |||
| BOOTH RICHARD H | Director | 53,778 | 869,052 | Sep 09 2014 | |||
| DAG Ventures Management III, LLC | 10% Owner | 1,474 | 23,820 | Apr 15 2014 | |||
| DAWSON WILLIAM J | Chief Financial Officer | 14,284 | 230,829 | Mar 22 2017 | |||
| DEMSKI MARTHA J | Director | 8,000 | 129,280 | Jun 08 2021 | |||
| Dier Mardi | Director | 5,000 | 80,800 | Jun 05 2020 | |||
| Ericson William W. | Director | 5,000 | 80,800 | Jun 05 2020 | |||
| Ericson William W. | Director | 25,661 | 414,682 | Apr 15 2014 | |||
| GREAT POINT PARTNERS LLC | 10% Owner | 2,251,351 | 36,381,832 | Jun 21 2017 | |||
| GROOTWASSINK SARA L | Director | 0 | 0 | May 18 2015 | |||
| KING RICHARD | Chief Operating Officer | 48,856 | 789,513 | Jun 22 2018 | |||
| Knapp Jeffrey H | Chief Operating Officer | 0 | 0 | Feb 27 2015 | |||
| LIEBERBURG IVAN M | Director | 53,000 | 856,480 | Jun 05 2020 | |||
| LIEBERBURG IVAN M | Director | 78,000 | 1,260,480 | Feb 03 2015 | |||
| MacPhee John A | Director | 197,000 | 3,183,520 | Mar 16 2021 | |||
| MAHONEY DAVID L | Director | 115,153 | 1,860,872 | Jun 04 2021 | |||
| McClure Natalie | SVP, Product Development | 8,340 | 134,774 | Apr 20 2016 | |||
| McClure Natalie | SVP, Product Development | 840 | 13,574 | Feb 06 2015 | |||
| McFarlane Neil F. | Chief Executive Officer | 525,000 | 8,484,000 | Mar 03 2021 | |||
| MDV IX LP | 10% Owner | 4,023,364 | 65,017,562 | Sep 16 2016 | |||
| MDV VII LP | 10% Owner | 25,661 | 414,682 | Apr 16 2014 | |||
| MERRIWEATHER ALFRED G | Chief Financial Officer | 48,019 | 775,987 | Sep 23 2019 | |||
| Papapetropoulos Spyridon | Director | 20,975 | 338,956 | Jun 04 2021 | |||
| Patni Rajiv | Chief Medical Officer | 49,141 | 794,119 | Apr 10 2019 | |||
| Prentiss Christopher B | Chief Financial Officer | 145,017 | 2,343,475 | Mar 23 2021 | |||
| Rhodes Jennifer J | CBO, GC & Compliance Officer | 63,114 | 1,019,922 | Jun 21 2019 | |||
| RICHO ANNA | Director | 20,000 | 323,200 | Sep 01 2020 | |||
| Shin Grace | General Counsel | 0 | 0 | Dec 03 2014 | |||
| Shreedhar Vijay | Chief Commercial Officer | 165,735 | 2,678,278 | Jun 23 2021 | |||
| Went Gregory T | Chief Executive Officer | 232,541 | 3,757,863 | Apr 10 2019 |